Tutkijat / Oulu  | Ala-Kokko, L. |
 | Ala-Kokko, T(ero) |
 | Ala-Korpela, M(ika) |
 | Alahuhta, S. |
 | Alén, M(arkku) |
 | Antikainen, R. |
 | Anttonen, V(uokko) |
 | Biancari, F(austo) |
 | Bloigu, R(isto) |
 | Eskelinen, S. |
 | Flinkkilä, T(apio) |
 | Hakkola, J. |
 | Hallman, M. |
 | Hartikainen, A(nna)-L(iisa) |
 | Hausen, H. |
 | Hautala, N(ina) |
 | Hautala, T(imo) |
 | Heape, A. |
 | Herzig, K(arl)-H(einz) |
 | Hillbom, M. |
 | Hiltunen, J.K. |
 | Hörkko, S. |
 | Huikuri, H(eikki) |
 | Hukkanen J(anne) |
 | Ignatius, J. |
 | Isohanni, M. |
 | Jaakkola, J. |
 | Jaakkola, M(aritta) S. |
 | Jaakola, V-P. |
 | Jämsä, T(imo) |
 | Janhonen, S. |
 | Jartti, T(uomas) |
 | Järvelin, M(arjo)-R(iitta) |
 | Jokelainen, J(ari) |
 | Juffer, A(ndré) H. |
 | Junttila, J(uhani) |
 | Juvonen, T. |
 | Kaarteenaho, R(iitta) |
 | Kajantie, E(ero)*(THL/OY) |
 | Karppinen (Koivunen), P(eppi) |
 | Karppinen, J(aro) |
 | Karttunen, T.J. |
 | Keinänen-Kiukaanniemi, S(irkka) |
 | Kerkelä, R(isto) |
 | Kesäniemi, Y(rjö) A(ntero) |
 | Kettunen, J(ohannes) |
 | Kietzmann, T(homas). |
 | Kivirikko, K.I. |
 | Knuuttila, M. |
 | Koivukangas, J. |
 | Kursula, P(etri) |
 | Kyngäs, H. |
 | Larivaara, P. |
 | Larmas, M. |
 | Lehenkari, P(etri) |
 | Lehtiö, L(ari) |
 | Leppilahti, J. |
 | Luukinen, H. |
 | Mainio A |
 | Majamaa, K. |
 | Mäki, P(irjo) |
 | Mäkikallio, T(imo) H. |
 | Männikkö, M(inna) |
 | Manninen, A(ki). |
 | Martikainen, H(annu) |
 | Miettunen, J(ouko) |
 | Myllyharju, J(ohanna) |
 | Myllylä, R. |
 | Myllylä, V. |
 | Näyhä, S(imo) |
 | Neubauer, P. |
 | Nieminen, M(iika) T. |
 | Nieminen, P(entti) |
 | Niinimäki, J(aakko) |
 | Ohukainen, P(auli) |
 | Oikarinen, A. |
 | Oikarinen, K. |
 | Pelkonen, O(lavi) |
 | Petäjä-Repo, U.E. |
 | Pihlajaniemi, T(aina) |
 | Pirttiniemi, P(ertti) |
 | Puistola, U(lla) |
 | Rajaniemi, H.J. |
 | Räsänen, P. |
 | Raustia, A. |
 | Remes, A(nne) |
 | Risteli, J. |
 | Ristiniemi, J. |
 | Ruddock, L.W. |
 | Ruokonen, A. |
 | Ryynänen, M. |
 | Saarakkala, S. |
 | Saari, A. |
 | Salo, T(uula) |
 | Sándor, G(eorge) K. |
 | Savolainen, E-R. |
 | Savolainen, M.J. |
 | Savolainen, O. |
 | Sillanpää, M(ikko). |
 | Soininen, R. |
 | Sorri, M. |
 | Taanila, A. |
 | Tapiainen, T(erhi) |
 | Tervonen, O(smo) |
 | Timonen, M(arkku) |
 | Turpeenniemi-Hujanen, T. |
 | Tuukkanen, J(uha) |
 | Tuulonen, A. |
 | Uhari, M. |
 | Ukkola, O(lavi) |
 | Uusimaa, J. |
 | Vainio, O. |
 | Vainio, S. |
 | Väyrynen, J(uha) P. |
 | Veijola, J(uha) |
 | Veijola, R(iitta) |
 | Virokannas, H. |
 | Voipio, H(anna)-M(arja) |
 | Vuolteenaho, O. |
 | Weckström, M. |
 | Wei, GH. |
 | Wierenga, R.K. |
 | Winqvist, R(obert) |
 | Ylänne, J. |
 | Ylitalo, K(ari) | Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| The N-terminal domain of unknown function (DUF959) in collagen XVIII is intrinsically disordered and highly O-glycosylated | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates humanδ-opioid receptor turnover at the plasma membrane | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Site-specific <em>O</em>-Glycosylation by Polypeptide <em>N</em>-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulatesβ<sub>1</sub>-Adrenergic Receptor N-terminal Cleavage | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| The Parkinson's-disease-associated receptor GPR37 undergoes metalloproteinase-mediated N-terminal cleavage and ectodomain shedding | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| N-Glycan-dependent and -independent quality control of humanδ opioid receptor N-terminal variants | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Targeting opioid receptors with pharmacological chaperones | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Allele-specific N-glycosylation delays human surfactant protein B secretion in vitro and associates with decreased protein levels in vivo | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| β-Adrenergic agonists mediate enhancement of β1-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitro | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Cys-27 variant of humanδ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Phe27Cys polymorphism of the human delta opioid receptor predisposes cells to compromised calcium signaling | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Human delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| N-glycan-mediated quality control in the endoplasmic reticulum is required for the expression of correctly folded delta-opioid receptors at the cell surface | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| The endoplasmic reticulum Ca2+-pump SERCA2b interacts with G protein-coupled receptors and enhances their expression at the cell surface | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Expression of the mature luteinizing hormone receptor in rodent urogenital and adrenal tissues is developmentally regulated at a posttranslational level | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Pharmacological chaperones: a new twist on receptor folding | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Structure and functional significance of the carbohydrates of the LH/CG receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Structural characterization of the carbohydrates of the rat ovarian luteinizing hormone/chorionic gonadotropin receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Significance of the extracellular domain and the carbohydrates of the human neutrophil N-formyl peptide chemotactic receptor for the signal transduction by the receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Significance of the carbohydrate moiety of the rat ovarian luteinizing-hormone/chorionic-gonadotropin receptor for ligand-binding specificity and signal transduction | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Rat and human neutrophil N-formyl-peptide chemotactic receptors. Species difference in the glycosylation of similar 35-38 kDa polypeptide cores | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Significance of the glycan moiety of the rat ovarian luteinizing hormone/chorionic gonadotropin (CG) receptor and human CG for receptor-hormone interaction | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Receptors of glycoprotein hormones | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Subunit interaction of human chorionic gonadotropin (hCG) with rat ovarian luteinizing hormone (LH)/CG receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Structural features of the LH/CG receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Molecular structure of the luteinizing hormone receptor | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications. | Petäjä-Repo, U.E. | 315 days | save |  |  |  | |
| Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function. | Petäjä-Repo, U.E. | 316 days | save |  |  |  | |
| The N-terminal Domain of Unknown Function (DUF959) in Collagen XVIII is Intrinsically Disordered and Highly O-glycosylated. | Petäjä-Repo, U.E. | 862 days | save |  |  |  | |
| Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates humanδ-opioid receptor turnover at the plasma membrane. | Petäjä-Repo, U.E. | 1210 days | save |  |  |  | |
| Site-specific O-glycosylation by Polypeptide GalNAc-transferase T2 Co-regulates Beta1-adrenergic Receptor N-terminal Cleavage. | Petäjä-Repo, U.E. | 1478 days | save |  |  |  | |
| Parkinson's disease-associated GPR37 undergoes metalloproteinase-mediated N-terminal cleavage and ectodomain shedding. | Petäjä-Repo, U.E. | 1840 days | save |  |  |  | |
| N-Glycan Dependent and Independent Quality Control of Human Delta Opioid Receptor N-Terminal Variants. | Petäjä-Repo, U.E. | 2487 days | save |  |  |  | |
| Targeting opioid receptors with pharmacological chaperones. | Petäjä-Repo, U.E. | 2624 days | save |  |  |  | |
| Allele-specific N-glycosylation delays human surfactant protein B secretion in vitro and associates with decreased protein levels in vivo. | Petäjä-Repo, U.E. | 2731 days | save |  |  |  | |
| ?-Adrenergic Agonists Mediate Enhancement of ?1-Adrenergic eceptor N-terminal Cleavage and Stabilization in Vivo and in Vitro. | Petäjä-Repo, U.E. | 3055 days | save |  |  |  | |
|  report | next » | |
|